Pregnancy outcomes after frozen‐thawed embryo transfer in women with COVID‐19 history: A prospective cohort study

Author:

Huang Jialyu12ORCID,Liu Yuxin3,Wang Jiawei4,Xu Dingfei1,Huang Zhihui1,Li Mengxi1,Huang Lingling1,Fan Lu1,Liu Peipei1,Xie Qiqi1,Li Zengming2,Wu Qiongfang1ORCID,Lin Jiaying5,Xia Leizhen1,Tian Lifeng1ORCID

Affiliation:

1. Center for Reproductive Medicine, Jiangxi Maternal and Child Health Hospital, Jiangxi Branch of National Clinical Research Center for Obstetrics and Gynecology Nanchang Medical College Nanchang China

2. Key Laboratory of Women's Reproductive Health of Jiangxi Province Nanchang China

3. Department of Clinical Medicine, School of Queen Mary Nanchang University Nanchang China

4. Division of Life Sciences and Medicine, Reproductive and Genetic Hospital, The First Affiliated Hospital of USTC University of Science and Technology of China Hefei China

5. Department of Assisted Reproduction, Shanghai Ninth People's Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

Abstract

AbstractThe clinical effect of Coronavirus disease 2019 (COVID‐19) on endometrial receptivity and embryo implantation remains unclear. Herein, we aim to investigate whether a COVID‐19 history adversely affect female pregnancy outcomes after frozen‐thawed embryo transfer (FET). This prospective cohort study enrolled 230 women who underwent FET cycles from December 2022 to April 2023 in an academic fertility center. Based on the history of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection before FET, women were divided into the infected group (n = 136) and the control group (n = 94). The primary outcome was the clinical pregnancy rate per cycle. Multivariate logistic regression analysis was conducted to adjust for potential confounders, while subgroup analysis and restricted cubic splines were used to depict the effect of postinfection time interval on FET. The results showed that the clinical pregnancy rate was 59.6% in the infected group and 63.9% in the control group (p = 0.513). Similarly, the two groups were comparable in the rates of biochemical pregnancy (69.1% vs. 76.6%; p = 0.214) and embryo implantation (51.7% vs. 54.5%; p = 0.628). After adjustment, the nonsignificant association remained between prior infection and clinical pregnancy (OR = 0.78, 95% CI: 0.42–1.46). However, the odds for clinical pregnancy were significantly lower in the ≤30 days subgroup (OR = 0.15, 95% CI: 0.03–0.77), while no statistical significance was detected for 31–60 days and >60 days subgroups compared with the uninfected women. In conclusion, our findings suggested that SARS‐CoV‐2 infection in women had no significant effect on subsequent FET treatment overall, but pregnancy rates tended to be decreased if vitrified‐thawed embryos were transferred within 30 days after infection. A 1‐month postponement should be rationally recommended, while further studies with larger sample groups and longer follow‐up periods are warranted for confirmation.

Publisher

Wiley

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3